# OnCo record nct05098132 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05098132/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05098132", "NCT05098132" ;
  schema:name "Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers"@en ;
  schema:alternateName "SYNERGY-101"@en ;
  schema:description "A phase 1/2 trial of Pemetrexed, Carboplatin in non-small-cell lung cancer and small-cell lung cancer, run by Synthekine, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05098132/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05098132> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2022-01-25" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/> ;
  onco:drugs <https://onco.cc/drugs/pemetrexed/>, <https://onco.cc/drugs/carboplatin/> .